Founded in 1985, Holley-Cotec is a member of KPC (Kunming Pharmaceuticals, Inc.). The company has built a complete industrial chain, integrating R&D, cultivation, raw material extraction, production and international marketing in the artemisinin industry. The company is gradually realizing strategic transformation. To build an internationalized pharmaceutical company based on Africa, oriented to Southeast Asia, and gradually step on the European and American markets. While continuously strengthening the leading and pioneering position in artemisinin industry, Holley-Cotec also concurrently engaged in the business of botanical and chemical medicines, as well as medical devices.

Holley-Cotec mainly focus on artemisinin-based antimalarial medicine. After years of efforts, the "DUO-COTECXIN", "Artem" series artemisinin-based antimalarial medicine, saved millions of lives in Africa and Southeast Asia, with their high efficiency, low prices, and great quality. Holley-Cotec has become a well-known brand in Africa and even the international medical field.

Holley-Cotec has built an excellently internationalized and also localized marketing team, set up five subsidiaries in Africa and established marketing network in nearly 40 countries in Africa and Southeast Asia.

Under the guidance of company’s vision “Health and Better Life”, Holley-Cotec actively fulfills social responsibility, and participates in public welfare undertakings. The company undertook human resource training program and international aid programs toward Africa entrusted by the National Ministry of Commerce of China. By taking concrete actions to give back to Africa and society, Holley-Cotec has established a good image of Chinese enterprises.